Maeda, H., Hazama, S., Iwamoto, S., Oba, K., Tsunedomi, R., Okayama, N., . . . Nagata, N. (2019). Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials. Oncol Lett.
Citação norma ChicagoMaeda, Hiromichi, et al. "Association between Polymorphisms in EGFR and Tumor Response During Cetuximab and Oxaliplatin-based Combination Therapy in Metastatic Colorectal Cancer: Analysis of Data From Two Clinical Trials." Oncol Lett 2019.
MLA CitationMaeda, Hiromichi, et al. "Association between Polymorphisms in EGFR and Tumor Response During Cetuximab and Oxaliplatin-based Combination Therapy in Metastatic Colorectal Cancer: Analysis of Data From Two Clinical Trials." Oncol Lett 2019.